Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cellectis S.A. ADR (CLLS)

Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cellectis S.A. ADR 8 RUE DE LA CROIX JARRY PARIS LLE-DE-FRANCE I0 75013 FRA

www.cellectis.com Employees: 222 P: 33-1-81-69-16-00 F: +33 181691606

Sector:

Medical

Description:

Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.

Key Statistics

Overview:

Market Capitalization, $K 226,211
Enterprise Value, $K 149,971
Shares Outstanding, K 55,580
Float, K 46,459
% Float 83.59%
Short Interest, K 401
Short Float 0.00%
Days to Cover 3.61
Short Volume Ratio 0.47
% of Insider Shareholders 16.41%
% of Institutional Shareholders 63.90%

Financials:

Annual Sales, $ 49,220 K
Annual Net Income, $ -36,760 K
Last Quarter Sales, $ 37,160 K
Last Quarter Net Income, $ 590 K
EBIT, $ -26,410 K
EBITDA, $ -6,560 K

Growth:

1-Year Return 180.41%
3-Year Return 33.87%
5-Year Return -84.82%
5-Year Revenue Growth 114.09%
5-Year Earnings Growth 82.99%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 11/07/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -0.57
EPS Growth vs. Prev Qtr 104.17%
EPS Growth vs. Prev Year 104.35%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CLLS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.22%
Return-on-Assets % -15.77%
Profit Margin % -74.69%
Debt/Equity 0.81
Price/Sales 5.49
Price/Cash Flow N/A
Price/Book 2.25
Book Value/Share 1.81
Interest Coverage -0.70
60-Month Beta 2.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar